Home › Funds › Madison Avenue Partners, LP › INDV
Madison Avenue Partners, LP position in INDV
INDIVIOR PHARMACEUTICALS INC · Health Care
Madison Avenue Partners, LP reported holding 2,874,368 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$117.9M, representing 5.08% of its reported portfolio and ranking #9 among its reported holdings. Madison Avenue Partners, LP has disclosed INDV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Madison Avenue Partners, LP's INDV position evolved
Madison Avenue Partners, LP first disclosed a stake in INDV in Q3 2023 at 39,087 shares (US$902K). The position peaked in Q4 2025 at 6,280,502 shares, worth US$225.3M. Across 12 filings, Madison Avenue Partners, LP increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,874,368 shares valued at US$117.9M — a reduction of -1,440,794 shares quarter over quarter.. Notable position changes include a 125% increase in Q1 2024, a 1673% increase in Q3 2024, a 112% increase in Q1 2025 (shares rose 55% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 39.09K | $901.74K | New |
| Q4 2023 | 72.25K | $1.10M | Add |
| Q1 2024 | 162.90K | $3.49M | Add |
| Q2 2024 | 223.43K | $3.60M | Add |
| Q3 2024 | 3.96M | $38.62M | Add |
| Q4 2024 | 3.67M | $45.66M | Reduce |
| Q1 2025 | 7.79M | $74.26M | Add |
| Q2 2025 | 7.92M | $116.77M | Add |
| Q3 2025 | 6.46M | $155.84M | Reduce |
| Q4 2025 | 6.28M | $225.34M | Reduce |
| Q1 2026 | 4.32M | $131.53M | Reduce |
| Q2 2026 | 2.87M | $117.94M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INDV and 13F data
INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 53 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Two Seas Capital LP (US$131.6M), MANGROVE PARTNERS IM, LLC (US$109.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INDV
- OAKTREE CAPITAL MANAGEMENT LP 6.13M sh · $251.40M · Q2 2026
- Two Seas Capital LP 3.67M sh · $131.61M · Q3 2026
- MANGROVE PARTNERS IM, LLC 2.68M sh · $109.83M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.65M sh · $67.65M · Q2 2026
- Newtyn Management, LLC 1.31M sh · $53.58M · Q2 2026
- GENDELL JEFFREY L 1.10M sh · $44.98M · Q2 2026
- Soleus Capital Management, L.P. 1.06M sh · $43.66M · Q2 2026
- Claret Asset Management Corp 685.52K sh · $28.13M · Q2 2026
- Divisadero Street Capital Management, LP 601.86K sh · $24.69M · Q2 2026
- Melqart Asset Management (UK) Ltd 585.66K sh · $24.03M · Q2 2026
- Alta Fundamental Advisers LLC 404.53K sh · $16.60M · Q2 2026
- PFM Health Sciences, LP 401.21K sh · $16.46M · Q2 2026
More on Madison Avenue Partners, LP
FAQ
How long has Madison Avenue Partners, LP held INDV?
Madison Avenue Partners, LP has disclosed INDV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Madison Avenue Partners, LP's current position in INDV?
As of Q2 2026, Madison Avenue Partners, LP holds 2.87M shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $117.94M, representing 5.08% of its reported portfolio and ranking #9.
Has Madison Avenue Partners, LP been buying or selling INDV?
In the latest 13F filing (Q2 2026), Madison Avenue Partners, LP reduced its position in INDV. The position peaked in Q4 2025 at 6.28M shares.
Which other funds hold INDV?
Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Two Seas Capital LP, MANGROVE PARTNERS IM, LLC, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.